Your browser doesn't support javascript.
loading
Activation of NF-κB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes.
Ping, Zhen; Chen, Si; Hermans, Sjoerd J F; Kenswil, Keane J G; Feyen, Jacqueline; van Dijk, Claire; Bindels, Eric M J; Mylona, Athina M; Adisty, Niken M; Hoogenboezem, Remco M; Sanders, Mathijs A; Cremers, Eline M P; Lindenbergh-Kortleve, Dicky J; Samsom, Janneke N; van de Loosdrecht, Arjan A; Raaijmakers, Marc H G P.
Afiliação
  • Ping Z; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Chen S; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Hermans SJF; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Kenswil KJG; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Feyen J; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van Dijk C; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Bindels EMJ; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Mylona AM; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Adisty NM; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Hoogenboezem RM; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Sanders MA; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Cremers EMP; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
  • Lindenbergh-Kortleve DJ; Laboratory of Pediatrics, Division of Gastroenterology and Nutrition, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Samsom JN; Laboratory of Pediatrics, Division of Gastroenterology and Nutrition, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van de Loosdrecht AA; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
  • Raaijmakers MHGP; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. m.h.g.raaijmakers@erasmusmc.nl.
Leukemia ; 33(2): 536-541, 2019 02.
Article em En | MEDLINE | ID: mdl-30315231
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Biomarcadores Tumorais / NF-kappa B / Mediadores da Inflamação / Células-Tronco Mesenquimais / Hematopoese Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Biomarcadores Tumorais / NF-kappa B / Mediadores da Inflamação / Células-Tronco Mesenquimais / Hematopoese Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda